Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada;
Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.
Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):158-167. doi: 10.1073/pnas.1815495116. Epub 2018 Dec 24.
p97 is an essential hexameric AAA+ ATPase involved in a wide range of cellular processes. Mutations in the enzyme are implicated in the etiology of an autosomal dominant neurological disease in which patients are heterozygous with respect to p97 alleles, containing one copy each of WT and disease-causing mutant genes, so that, in vivo, p97 molecules can be heterogeneous in subunit composition. Studies of p97 have, however, focused on homohexameric constructs, where protomers are either entirely WT or contain a disease-causing mutation, showing that for WT p97, the N-terminal domain (NTD) of each subunit can exist in either a down (ADP) or up (ATP) conformation. NMR studies establish that, in the ADP-bound state, the up/down NTD equilibrium shifts progressively toward the up conformation as a function of disease mutant severity. To understand NTD functional dynamics in biologically relevant p97 heterohexamers comprising both WT and disease-causing mutant subunits, we performed a methyl-transverse relaxation optimized spectroscopy (TROSY) NMR study on a series of constructs in which only one of the protomer types is NMR-labeled. Our results show positive cooperativity of NTD up/down equilibria between neighboring protomers, allowing us to define interprotomer pathways that mediate the allosteric communication between subunits. Notably, the perturbed up/down NTD equilibrium in mutant subunits is partially restored by neighboring WT protomers, as is the two-pronged binding of the UBXD1 adaptor that is affected in disease. This work highlights the plasticity of p97 and how subtle perturbations to its free-energy landscape lead to significant changes in NTD conformation and adaptor binding.
p97 是一种必需的六聚体 AAA+ATP 酶,参与广泛的细胞过程。该酶的突变与一种常染色体显性神经疾病的病因有关,在这种疾病中,患者 p97 等位基因杂合,每个等位基因各有一个 WT 和致病突变基因的拷贝,因此,在体内,p97 分子在亚基组成上可以是异质的。对 p97 的研究主要集中在同六聚体构建体上,其中原体要么完全是 WT,要么包含一个致病突变,表明对于 WT p97,每个亚基的 N 端结构域(NTD)可以存在于 ADP 或 ATP 构象中。NMR 研究确定,在 ADP 结合状态下,随着疾病突变严重程度的增加,上/下 NTD 平衡逐渐向构象移动。为了了解包含 WT 和致病突变亚基的生物相关 p97 异六聚体中的 NTD 功能动力学,我们对一系列仅有一种原体类型被 NMR 标记的构建体进行了甲基横向弛豫优化光谱(TROSY)NMR 研究。我们的结果显示,相邻原体之间的 NTD 上/下平衡具有正协同性,使我们能够定义介导亚基之间变构通讯的互变异构途径。值得注意的是,突变亚基中扰动的 NTD 上/下平衡部分被相邻的 WT 原体恢复,UBXD1 接头的二分叉结合也被恢复,该接头在疾病中受到影响。这项工作强调了 p97 的可塑性,以及对其自由能景观的微小干扰如何导致 NTD 构象和接头结合的显著变化。